MAVERICK CAPITAL LTD
SuperinvestorMaverick Capital
- SEC CIK
- 0000934639
- Manager
- Lee Ainslie
- Style
- Hedge fund
RCKT holding history
ROCKET PHARMACEUTICALS, INC.
Every 13F filing in which Maverick Capital reported holding RCKT, plus the quarters it sold out. Changes compare share counts with the previous calendar quarter.
RCKT overviewAll 13F holders of RCKTFull portfolio
| Quarter | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Q2 2026 | 3,923,963 | $13.42M | 0.12% | +356,591+10.0% | Added |
| Q1 2026 | 3,567,372 | $12.77M | 0.15% | +1,054,262+42.0% | Added |
| Q4 2025 | 2,513,110 | $8.82M | 0.09% | −5,955,234−70.3% | Reduced |
| Q3 2025 | 8,468,344 | $27.61M | 0.37% | +104,531+1.2% | Added |
| Q2 2025 | 8,363,813 | $20.49M | 0.31% | +3,164,595+60.9% | Added |
| Q1 2025 | 5,199,218 | $34.68M | 0.62% | +3180.0% | Added |
| Q4 2024 | 5,198,900 | $65.35M | 1.18% | +1,080,228+26.2% | Added |
| Q3 2024 | 4,118,672 | $76.07M | 1.48% | +190,360+4.8% | Added |
| Q2 2024 | 3,928,312 | $84.58M | 1.60% | +40,000+1.0% | Added |
| Q1 2024 | 3,888,312 | $104.75M | 2.03% | −145,756−3.6% | Reduced |
| Q4 2023 | 4,034,068 | $120.9M | 2.49% | −1,595,902−28.3% | Reduced |
| Q3 2023 | 5,629,970 | $115.36M | 2.70% | +1,250,000+28.5% | Added |
| Q2 2023 | 4,379,970 | $87.03M | 1.86% | −27,653−0.6% | Reduced |
| Q1 2023 | 4,407,623 | $75.5M | 1.94% | +1,011,805+29.8% | Added |
| Q4 2022 | 3,395,818 | $66.46M | 1.62% | +863,452+34.1% | Added |
| Q3 2022 | 2,532,366 | $40.42M | 0.91% | 00.0% | Unchanged |
| Q2 2022 | 2,532,366 | $34.85M | 0.87% | +399,200+18.7% | Added |
| Q1 2022 | 2,133,166 | $33.83M | 0.61% | +238,200+12.6% | Added |
| Q4 2021 | 1,894,966 | $41.37M | 0.50% | +234,850+14.1% | Added |
| Q3 2021 | 1,660,116 | $49.62M | 0.55% | +1,486,229+854.7% | Added |
| Q2 2021 | 173,887 | $7.7M | 0.07% | +173,887 | New |